Top compounds associated with response to ASXL3


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel gCSI pan-cancer AAC -0.065 0.2
mRNA thapsigargin gCSI pan-cancer AAC -0.063 0.3
mRNA Crizotinib gCSI pan-cancer AAC -0.057 0.3
mRNA Irinotecan gCSI pan-cancer AAC -0.05 0.3
mRNA paclitaxel gCSI pan-cancer AAC -0.037 0.5
mRNA Rapamycin gCSI pan-cancer AAC -0.019 0.7
Download CSV